RenovoRx, Inc. (RNXT)
1.68
-0.01
(-0.59%)
USD |
NASDAQ |
Sep 21, 16:00
1.64
-0.04
(-2.38%)
After-Hours: 20:00
RenovoRx Price : 1.68 for Sept. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 1.74 | 1.75 | 1.67 | 1.69 | 566879.0 |
| Sep 17, 2026 | 1.60 | 1.77 | 1.58 | 1.73 | 636082.0 |
| Sep 16, 2026 | 1.73 | 1.73 | 1.55 | 1.55 | 1.036M |
| Sep 15, 2026 | 1.692 | 1.73 | 1.60 | 1.72 | 1.033M |
| Sep 14, 2026 | 1.75 | 1.85 | 1.66 | 1.69 | 579669.0 |
| Sep 11, 2026 | 1.77 | 1.820 | 1.67 | 1.76 | 1.168M |
| Sep 10, 2026 | 1.97 | 1.99 | 1.71 | 1.77 | 1.641M |
| Sep 09, 2026 | 2.15 | 2.30 | 1.935 | 1.995 | 1.734M |
| Sep 08, 2026 | 2.31 | 2.345 | 2.151 | 2.20 | 1.207M |
| Sep 04, 2026 | 2.35 | 2.540 | 2.28 | 2.39 | 2.092M |
| Sep 03, 2026 | 2.52 | 2.52 | 1.98 | 2.37 | 3.825M |
| Sep 02, 2026 | 2.14 | 2.59 | 2.14 | 2.52 | 4.135M |
| Sep 01, 2026 | 1.91 | 2.20 | 1.83 | 2.11 | 3.314M |
| Aug 31, 2026 | 1.735 | 1.97 | 1.65 | 1.93 | 3.294M |
| Aug 28, 2026 | 1.48 | 1.679 | 1.470 | 1.67 | 1.055M |
| Aug 27, 2026 | 1.47 | 1.55 | 1.43 | 1.48 | 428932.0 |
| Aug 26, 2026 | 1.41 | 1.55 | 1.385 | 1.49 | 763831.0 |
| Aug 25, 2026 | 1.30 | 1.56 | 1.27 | 1.42 | 1.345M |
| Aug 24, 2026 | 1.33 | 1.358 | 1.24 | 1.25 | 264048.0 |
| Aug 21, 2026 | 1.30 | 1.325 | 1.25 | 1.32 | 233271.0 |
| Aug 20, 2026 | 1.29 | 1.35 | 1.23 | 1.32 | 381177.0 |
| Aug 19, 2026 | 1.17 | 1.337 | 1.15 | 1.315 | 582345.0 |
| Aug 18, 2026 | 1.21 | 1.269 | 1.12 | 1.17 | 498972.0 |
| Aug 17, 2026 | 1.415 | 1.505 | 1.180 | 1.20 | 1.223M |
| Aug 14, 2026 | 1.27 | 1.45 | 1.26 | 1.40 | 1.007M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Enanta Pharmaceuticals, Inc. | 12.11 |
| Travere Therapeutics, Inc. | 62.83 |
| REGENXBIO, Inc. | 7.88 |
| Krystal Biotech, Inc. | 333.80 |
| ACADIA Pharmaceuticals, Inc. | 26.40 |
Price Related Metrics
| PS Ratio | 33.71 |
| Price to Book Value | 8.443 |
| Earnings Yield | -18.69% |
| Market Cap | 75.80M |